308 POSTER Synergistic anti-tumour activity of oncolytic Reovirus and cisplatin in a B16.F10 mouse melanoma model

Overview of attention for article published in EJC Supplements, October 2008

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent: 3 patents

So far, Altmetric has seen 3 patents that reference this research output.

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

Grant US-8470312-B2

United States of America

ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY

Application EP-2296679-A4

European Patent Office

ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY

Application EP-2296679-A1

European Patent Office

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.